New Diabetes Treatments-Enhanced blood flow

Three diabetes treatments with entirely new modes of action were approved: exenatide injection for people with type 2 diabetes, pramlintide injection as an add-on to insulin therapy for people with type 1 or type 2 diabetes and Sitagliptin also for people with type 2 diabetes. Some diabetes medications help the pancreas release more insulin (if you have type 2 diabetes), others help cells use insulin better, and others keep the liver from releasing too much glucose. The new treatments focus action on hormones called incretins.
Exenatide injection:

  • is injected twice a day at mealtime
  • is for those with type 2 diabetes who have been unable to control blood glucose with oral medicines
  • improves blood glucose control by mimicking incretin hormones, stimulating insulin and slowing stomach-emptying
  • leads to weight loss because patients will feel full faster and stop eating
  • can cause nausea

Exenatide extended release  is  injected once per week is for those with type 2 diabetes who have been unable to control blood glucose with oral medicines  that helps to improves blood glucose control by mimicking incretin hormones, stimulating insulin and slowing stomach-emptying leads to weight loss because patients will feel full faster and stop eating which can cause nausea.

Pramlintide acetate is intended for those with type 1 or type 2 diabetes who use insulin

  • is injected at mealtime
  • is to never mix with insulin in one syringe; which creates the need for an additional injection for the patient
  • used for better glucose control, reduction in blood glucose spikes, reduction in food intake, whichleads to weight loss
  • can cause nausea or hypoglycemia (dangerously low blood glucose)

Sitagliptin Saxagliptin and linagliptin-All three of these pills

  • are taken once a day
  • are for type 2 diabetes
  • do not promote weight gain
  • are often used in combination with metformin
  • have very little, if any, side effects
  • Should be taken with caution for patients with renal disease (dose should be decreased)
  • slows the breakdown of incretins, so insulin is released over a longer period of time

  • Liraglutide Injection
  • Exenatide Injection
  • Exenatide extended release Injection
  • Pramlintide acetate(Mealtime Injection)
  • Sitagliptin and Metformin (Dipeptidyl Peptidase-4 Inhibitors)
  • Saxagliptin and Metformin
  • Linagliptin and Metformin

Related Conference of New Diabetes Treatments-Enhanced blood flow

August 22-23, 2022

Global Meeting on Diabetes and Nursing Care

Prague, Czech Republic
August 22-23, 2022

Global Summit on Endocrinology

Budapest, Hungary
August 22-23, 2022

European Endocrinology and Diabetes Congress

Budapest, Hungary
August 29-30, 2022

Annual Congress on Endocrinology & Disorders

Berlin, Germany
September 19-20, 2022

4th International Conference on Cell Metabolism

Amsterdam, Netherlands
September 19-20, 2022

18th International Conference on Diabetes & Care

Amsterdam, Netherlands
September 22-23, 2022

3rd World Summit on Diabetes

Rome, Italy
September 23-24, 2022

World Congress on Endocrine and Diabetes

Rome, Italy
September 26-27, 2022

6th Annual Conference on Diabetes and Endocrinology

Amsterdam, Netherlands
September 27-28, 2022

2nd Annual Summit on Diabetes and Endocrinology

Rome, Italy
September 28-29, 2022

16th European Diabetes and Endocrinology Congress

Rome, Italy
October 14-15, 2022

2nd Global congress on Endocrinology and Gynecology

Sydney, Australia
November 09-10, 2022

31st International Diabetes and Healthcare Conference

Madrid, Spain
November 09-10, 2022

2nd International Congress and Expo on Diabetic Care

Bangkok, Thailand
November 16-17, 2022

World congress and Expo on Diabetes

Manila, Philippines
November 22-23, 2022

18th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands
November 28-29, 2022

International Conference on Diabetes & Heart Diseases

Yokohama, Japan
November 28-29, 2022

14th World Congress on Endocrinology and Metabolic Disorders

Sydney, Australia
January 30-31, 2023

6th Annual Meeting on Diabetes and Endocrinology

Barcelona, Spain
February 22-23, 2023

32nd European Diabetes Congress

Madrid,
May 15-16, 2023

4th Global summit on Diabetes and Endocrinology

Madrid, Spain

New Diabetes Treatments-Enhanced blood flow Conference Speakers

Recommended Sessions

Related Journals

Are you interested in